HLX42 targets EGFR on the cell surface; after internalization it releases a topoisomerase I inhibitor that causes DNA damage and apoptosis. DNA topoisomerase I is the intracellular enzyme inhibited by the payload, not the antigen used for targeting, so cells aren’t killed because they express TOP1 per se (except via EGFR-mediated delivery or bystander effect).